337 related articles for article (PubMed ID: 24157371)
41. Effect of Ovocystatin on Amyloid β 1-42 Aggregation-In Vitro Studies.
Stańczykiewicz B; Goszczyński TM; Migdał P; Piksa M; Pawlik K; Gburek J; Gołąb K; Konopska B; Zabłocka A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982505
[TBL] [Abstract][Full Text] [Related]
42. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
43. Inhibiting and reversing amyloid-β peptide (1-40) fibril formation with gramicidin S and engineered analogues.
Luo J; Otero JM; Yu CH; Wärmländer SK; Gräslund A; Overhand M; Abrahams JP
Chemistry; 2013 Dec; 19(51):17338-48. PubMed ID: 24218178
[TBL] [Abstract][Full Text] [Related]
44. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty.
Durairajan SS; Yuan Q; Xie L; Chan WS; Kum WF; Koo I; Liu C; Song Y; Huang JD; Klein WL; Li M
Neurochem Int; 2008; 52(4-5):741-50. PubMed ID: 17964692
[TBL] [Abstract][Full Text] [Related]
45. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
46. A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer.
Nie RZ; Zhu W; Peng JM; Ge ZZ; Li CM
Biochimie; 2016 Jun; 125():204-12. PubMed ID: 27079519
[TBL] [Abstract][Full Text] [Related]
47. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
49. Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro.
Wisniewski T; Castano E; Ghiso J; Frangione B
Ann Neurol; 1993 Oct; 34(4):631-3. PubMed ID: 8215255
[TBL] [Abstract][Full Text] [Related]
50. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
[TBL] [Abstract][Full Text] [Related]
51. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
52. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte.
Ryu J; Kanapathipillai M; Lentzen G; Park CB
Peptides; 2008 Apr; 29(4):578-84. PubMed ID: 18304694
[TBL] [Abstract][Full Text] [Related]
54. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
55. Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro.
Tang MK; Zhang JT
Acta Pharmacol Sin; 2001 Apr; 22(4):380-4. PubMed ID: 11742594
[TBL] [Abstract][Full Text] [Related]
56. Mathematical modeling of gallic acid release from chitosan films with grape seed extract and carvacrol.
Rubilar JF; Cruz RMS; Zuñiga RN; Khmelinskii I; Vieira MC
Int J Biol Macromol; 2017 Nov; 104(Pt A):197-203. PubMed ID: 28587960
[TBL] [Abstract][Full Text] [Related]
57. Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.
Sakalauskas A; Ziaunys M; Smirnovas V
Sci Rep; 2020 Sep; 10(1):14466. PubMed ID: 32879381
[TBL] [Abstract][Full Text] [Related]
58. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
59. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of toxicity and protofibril formation in the amyloid-beta peptide beta(25-35) using N-methylated derivatives.
Doig AJ; Hughes E; Burke RM; Su TJ; Heenan RK; Lu J
Biochem Soc Trans; 2002 Aug; 30(4):537-42. PubMed ID: 12196132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
